References
- Rothenberg M L, Eckardt J R, Kuhn J G, Burris H A, III, Nelson J, Hilsenbeck S G, et al. Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. J Clin Oncol 1996; 14: 1128–1135
- Fukuoka M, Niitani H, Suzuki A, Motomiya M, Hasegawa K, Nishiwaki Y, et al. A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. J Clin Oncol 1992; 10: 16–20
- Masuda N, Fukuoka M, Kusunoki Y, Matsui K, Takifuji N, Kudoh S, et al. CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer. J Clin Oncol 1992; 10: 1225–1229
- Friedman H S, Petros W P, Friedman A H, Schaaf L J, Kerby T, Lawyer J, et al. Irinotecan therapy in adults with recurrent or progressive malignant glioma. J Clin Oncol 1999; 17: 1516–1525
- Pedersen-Bjergaard J, Andersen M K, Christiansen D H, Nerlov C. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood 2002; 99: 1909–1912
- Pui C H, Behm F G, Raimondi S C, Dodge R K, George S L, Rivera G K, et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med 1989; 321: 136–142
- Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood 1995; 86: 3542–3552
- Smith S M, LeBeau M M, Huo D, Karrison T, Sobecks R M, Anastasi J, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 2003; 102: 43–52
- Buxhofer-Ausch V, Hinterberger-Fischer M, Hinterberger W. BCR-ABL positive blast crisis of chronic myeloid leukemia emerging in a case of metastatic colorectal cancer 3 months after completion of an 8-month course of cetuximab and irinotecan. Eur J Haematol 2006; 76: 447–448, Epub 2006 Feb 23
- Merrouche Y, Mugnert F, Cahn J Y. Secondary acute promyelocytic leukemia following irinotecan and oxaliplatin for advanced colon cancer. Ann Oncol 2006; 17: 1025–1026, Epub 2005 Nov 17
- Carniero B A, Kaminer L, Eldibany M, Sreekantaiah C, Kaul K, Locker G Y. Oxaliplatin related acute myelogenous leukemia. Oncologist 2006; 11: 261–262